SOLVAY COMPLETES ACQUISITION OF FOURNIER PHARMA

Solvay announced today that it has completed the acquisition of 100% of Fournier Pharma, following the successful completion of social and regulatory procedures worldwide. The process of integrating Fournier Pharma and Solvay Pharmaceuticals will begin with the creation of a number of Integration Teams whose task will be to identify the best operational solutions for combining all activities. A complete analysis of Fournier Pharma's structures is planned over the upcoming 12 months in order to prepare the deployment of the future organization within Solvay Pharmaceuticals.

Bourse (http://bourse.lci.fr/detail_actualite.phtml?news=2830541)